Search results for 5971

RelB (phospho Ser573) antibody, Genetex, GTX50283

V-Rel Reticuloendotheliosis Viral Oncogene Homolog B Phospho-Ser552 (RELB pS552) Antibody, Abbexa, abx325824

RELB (pS552) Antibody is a Rabbit Polyclonal against RELB (pS552).

V-Rel Reticuloendotheliosis Viral Oncogene Homolog B (RELB) Antibody, Abbexa, abx333808

RELB Antibody is a Rabbit Polyclonal against RELB.

RelB Antibody (YA5890), MedChemexpress, HY-P86198

RelB Antibody (YA5890) is a Rabbit-derived and non-conjugated IgG monoclonal antibody, targeting to RelB.

Transcription Factor Relb (RELB) Antibody, Abbexa, abx455779

Transcription Factor Relb (RELB) Antibody is a Rabbit polyclonal antibody for the detection of Human Transcription Factor Relb (RELB).

V-Rel Reticuloendotheliosis Viral Oncogene Homolog B (RELB) Antibody (HRP), Abbexa, abx338017

RELB Antibody (HRP) is a Rabbit Polyclonal against RELB.

RelB antibody, Genetex, GTX102332

RelB antibody, Genetex, GTX102333

V-Rel Reticuloendotheliosis Viral Oncogene Homolog B (RELB) Antibody, Abbexa, abx011457

V-Rel Reticuloendotheliosis Viral Oncogene Homolog B (RELB) Antibody is a Rabbit Polyclonal antibody for the detection of RELB. NF-kappa-B is a pleiotropic transcription factor which is present in almost all cell types and is involved in many biological processed such as inflammation, immunity, differentiation, cell growth, tumorigenesis and apoptosis. NF-kappa-B is a homo-or heterodimeric complex formed by the Rel-like domain-containing proteins RELA/p65, RELB, NFKB1/p105, NFKB1/p50, REL and NFKB2/p52. The dimers bind at kappa-B sites in the DNA of their target genes and the individual dimers have distinct preferences for different kappa-B sites that they can bind with distinguishable affinity and specificity. Different dimer combinations act as transcriptional activators or repressors, respectively. NF-kappa-B is controlled by various mechanisms of post-translational modification and subcellular compartmentalization as well as by interactions with other cofactors or corepressors. NF-kappa-B complexes are held in the cytoplasm in an inactive state complexed with members of the NF-kappa-B inhibitor (I-kappa-B) family. In a conventional activation pathway, I-kappa-B is phosphorylated by I-kappa-B kinases (IKKs) in response to different activators, subsequently degraded thus liberating the active NF-kappa-B complex which translocates to the nucleus. NF-kappa-B heterodimeric RelB-p50 and RelB-p52 complexes are transcriptional activators. RELB neither associates with DNA nor with RELA/p65 or REL. Stimulates promoter activity in the presence of NFKB2/p49. As a member of the NUPR1/RELB/IER3 survival pathway, may provide pancreatic ductal adenocarcinoma with remarkable resistance to cell stress, such as starvation or gemcitabine treatment. Regulates the circadian clock by repressing the transcriptional activator activity of the CLOCK-ARNTL/BMAL1 heterodimer in a CRY1/CRY2 independent manner. Increased repression of the heterodimer is seen in the presence of NFKB2/p52.

RelB Antibody (YA098), MedChemexpress, HY-P80306

RelB Antibody (YA098) is a Rabbit-derived and non-conjugated IgG monoclonal antibody, targeting to RelB.